Registration Now Open for InformEx 2015 in New Orleans

  • InformEx,New Orleans,InformEx 2015,Chemical

NEW YORK, Sept. 8, 2014 /PRNewswire/ -- Registration is now live for InformEx, North America's only event of its kind offering educational resources and business partnering opportunities for buyers and sellers of high-value chemistry.

More than 3,000 attendees from top pharmaceutical, fine chemical and specialty chemical companies will convene at the Ernest N. Morial Convention Center in New Orleans from Feb. 3-5 to take part in the InformEx 2015 conference and its esteemed networking opportunities.

Attendees may register via the following link:

For the first time, the 2015 event will offer a tiered badge pricing structure, which increases accessibility for attendees with varying business and networking goals. Attendees can choose from a basic expo package for $195, a networking-level package that also includes admission to receptions and conference sessions for $395, and an all-inclusive package that provides additional access to technology showcases, the showcase luncheon and daily meals for $595 ($395 for exhibitors).

The 2015 conference also will provide innovation-focused education sessions that lend expert guidance to ongoing industry changes. Sessions will spotlight innovation and opportunities in rapidly growing fields such as green chemistry, shale gas, personalized medicine, 3D printing and more. Some sessions also will provide attendees with insights into trade and regulation, intellectual property and the latest business trends in industries such as the fine and specialty chemicals and pharmaceuticals. Attendees can expect to hear from leading companies and organizations such as the ACS Green Chemistry Institute, Codexis, Dr. Reddy's Custom Pharmaceutical Services, Kodak Specialty Chemical, SOCMA, Xerox Research Center Canada and many more.

"InformEx 2015 features a lineup of marquee thought leaders that will share insights on the latest trends that are shaping our industry landscape," said Robyn Duda, InformEx brand director. "We've channeled feedback from our strategic advisory board to emphasize business growth and innovation, with the goal of preparing attendees for the opportunities that the chemical industry presents."

InformEx 2015 also will feature a new cGMP zone in partnership with CPhI Worldwide and a more convenient three-day schedule (Tuesday-Thursday) to meet the needs of the InformEx community.

Among other program enhancements attendees will experience at the New Orleans event:

  • Co-location with the 6th Annual Next Generation Bio-Based & Sustainable Chemicals Summit. Attendees of InformEx 2015 will receive a 25% off admission to the 6th Annual Next Generation Bio-Based & Sustainable Chemicals Summit, produced by Infocast and recognized globally as the deal-making hub for the bio-based industry. The summit will be held concurrently with InformEx at the Morial Convention Center, bringing together bio-based tech start-ups, brand owners, feedstock providers, financiers, strategic venture capitalists, OEMs and retailers from around the world to explore bio-based chemicals as the answer to a number of market drivers.

  • Specialty zone. The InformEx Specialty Zone will provide a focused area for custom, contract and toll manufacturers serving specialty chemical industries, including: Agrochemicals & Crop Protection, Adhesives & Polymers, Construction, Electronic & IT, Flavors & Fragrances, Food & Beverage, Sealants & Coatings, Petrochemical & Energy and Personal Care.

  • Buyer panels. By popular demand, InformEx is re-introducing InformEx Buyer Panels, designed for suppliers to hear directly from procurement professionals in a Q&A format. Buyer panels will cover the pharmaceutical, agrochemical and industrial markets.

InformEx is a marquee event for manufacturers, distributors and service providers to the fine, specialty, and custom chemical industry. Visit to learn more about attending or exhibiting at InformEx 2015 in New Orleans.

About InformEx
InformEx is committed to the continuous advancement of the fine, specialty, and custom chemicals industry by providing networking tools, educational opportunities and community collaboration forums — all designed to accelerate growth in the changing chemical enterprise landscape. The annual InformEx event is the premier must-attend exposition for the chemical industry for the past 30 years, providing a platform for in-person networking and business development. Each year the event brings together an international mix of more than 3,000 fine and specialty chemicals professionals and hundreds of exhibitors. To learn more, visit InformEx is produced by UBM plc, a global events-led marketing services and communications company. For more information, visit

Photo -


This link:

The ChemCD compiler finishing, shall not be reproduced without permission, for reprint please indicate the source。

comments powered by Disqus


Related News

Merck Announces FDA Acceptance of Biologics License Application for Bezlotoxumab, an Investigational Antitoxin for Prevention of Clostridium Difficile Infection Recurrence

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bezlotoxumab, an investigational antitoxin for prevention of Clostridium difficile (C. difficile) infection recurrence.

Sanofi and Regeneron Announce Sarilumab Biologics License Application Accepted for Review by US FDA

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for sarilumab.

First data backs efficacy of BMS' novel HIV drug

A Bristol-Myers Squibb (BMS) drug that causes immature HIV particles to be released from cells early, interrupting their lifecycle, has cleared a proof-of-concept study.

EU Rules Could Restrict Genetic Testing

Genetic testing describes the application of laboratory methods to look at a person’s genes (the inherited DNA instructions). Genetic tests can be used to diagnose a genetic condition; screen for a risk of developing a particular health problems; for the selection of treatments; or to assess responses to treatments.

CHMP adopts positive opinion of Edurant in adolescents with HIV-1

The CHMP has adopted a positive opinion recommending a change to the terms of the marketing authorisation for Janssen’s Edurant (rilpivirine) in the EU to extend the indication to adolescent patients aged 12 to <18 years with human immunodeficiency virus-1 (HIV-1) infection

FDA finds mystery 'deficiencies' with Neos' long-acting Ritalin on the eve of approval

Neos Therapeutics got an ominous note from the FDA just weeks ahead of the expected approval date for its long-acting ADHD treatment, clouding the future of the company's lead asset.

Pfizer's once-failed cancer drug wins the FDA's 'breakthrough' tag

Pfizer has found new hope for a former pipeline standout, picking up the FDA's coveted breakthrough therapy designation for a Phase III reclamation project in oncology.